Meta-analysis of the efficacy of treatments for newly diagnosed and relapsed/refractory multiple myeloma with del(17p).

导出 OA

翻译打印收藏纠错

作者： Jinghua,Liu ^[1] ; Hui,Yang ^[1] ; Xiaochan,Liang ^[2] ; Yuxin,Wang ^[1] ; Jian,Hou ^[3] ; Yanqin,Liu ^[1] ; Jigang,Wang ^[1] ; Fan,Zhou ^[1]

作者单位： Department of Hematology, The General Hospital of Shenyang Military, Shenyang, China. ^[1] Department of Clinical Medicine, Shenyang Pharmaceutical University, Shenyang, China. ^[2] Department of Hematology, The Myeloma and Lymphoma Center, Chang Zheng Hospital, The Second Military Medical University, Shanghai, China. ^[3]

关键词 bortezomib carfilzomib lenalidomide multiple myeloma del(17p)pomalidomide

DOI 10.18632/oncotarget.18722

PMID 28977957

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交